Participants were aged between 40 and 79 at the start of the study, which began in the ’90s ― but the data which scientists ...

Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...

Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars ...

Short-term memory loss can be a sign of early-stage Alzheimer's disease. It can manifest as difficulty creating new memories or problems retrieving them. For example, someone with early Alzheimer's ...

Eric Deggans is NPR's first full-time TV critic, also serving as media analyst and guest host for the network. Deggans came to NPR in 2013 from the Tampa Bay Times, where he served as TV/Media ...

A broad investigation led to corruption charges against Mayor Eric Adams of New York. Now the Justice Department is pushing to dismiss the case. By Lola Fadulu and Alyce McFadden More than three ...

The Pentagon said it would fire 5,400 civilian probationary workers beginning next week, and officials say a wave of much ...

With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...

Eric Katz writes about federal agency operations and management. His deep coverage of Veterans Affairs, Homeland Security, the Environmental Protection Agency and U.S. Postal Service has earned ...